C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/1999
10/13/1999	EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999	EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999	EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999	EP0567575B1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof
10/13/1999	EP0564592B1 Liver enriched transcription factor
10/13/1999	CN1231701A Method and apparatus for detecting bacteria
10/13/1999	CN1231696A Homocysteine desulphurase from the protozoan trichomonas vaginalis
10/13/1999	CN1231694A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
10/13/1999	CN1231673A Polynucleotide and its use for modulating a defence response in plants
10/13/1999	CN1231341A Kit for determining alanine aminopherase
10/12/1999	US5965736 Luciferins able to react with a phosphatase enzyme; detection of enzyme conjugates; use with charge-coupled devices, e.g. including charge-coupling device cameras and luminometers; durability; efficiency; immunoassays
10/12/1999	US5965726 Method of eliminating inhibitory/ instability regions of mRNA
10/12/1999	US5965722 Oligonucleotide with methylene(methylimino) linkages alternating with phosphorothioate or phosphodiester linkages; with increased nuclease resistance, stability, affinity for messenger rna; anticarcinogenic/antiarrhythmia agents
10/12/1999	US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999	US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999	US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents
10/12/1999	US5965699 Assay for the proteolytic activity of serotype a from clostridium botulinum
10/12/1999	US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999	US5965453 A test apparatus with a transparent tube having at one end a sample unit, the other end a detachable or nondetachable unit which are connected, and includes a cover with a probe and a swab at one end; rapid, efficient and disposable apparatus
10/12/1999	US5965449 Method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders
10/12/1999	US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999	US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999	US5965417 Arabidepsi thaliana proteins having Δ-5,7-sterol-Δ-7-reductase activity
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965409 Kit containing at least three oligodeoxynucleotide primers with specific nucleotide sequences including restriction endonuclease recognition site; for isolating messenger rnas as complementary dna using polymerase amplification
10/12/1999	US5965408 Amplifying heterologous, single stranded dna complementary to a gene with random oligonucleotide primers; prematurely terminating synthesis forming variable length strands; denaturing and reannealing strands; repeating cycle
10/12/1999	US5965396 Human lymph node derived GTPase
10/12/1999	US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999	US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999	US5965380 Calibration of electrochemical sensor by withdrawing single calibration sample from animal, determining concentration of analyte, correlating with at least one signal generated by implanted working electrode with analyte responsive layer
10/12/1999	US5965375 Diagnostic tests and kits for Clostridium difficile
10/12/1999	US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999	US5965369 A protein; diagnosis/treatment for reproductive disorders, gastrointestinal disorders, aquired immune deficiency syndrome, parkison's/alzheimer's/huntington's disease; anticarcinogenic/antiinflammatory/antidiabetic agents
10/12/1999	US5965368 Determining protein-protein interactions by counterselection of two test proteins expressed in two separate nucleic acid libraries and measuring level of expression of reporter gene operably linked to a dna-binding-protein recognition sites
10/12/1999	US5965367 Purified bradykinin B1 receptor
10/12/1999	US5965366 Determining the protein binding pattern of an oligonucleotide probe in a patient lymphocyte sample and a healthy idividual, comparing patterns of binding, assessing the immune index of the patient
10/12/1999	US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999	US5965364 Method for selecting functional deoxyribonucleotide derivatives
10/12/1999	US5965363 Methods of preparing nucleic acids for mass spectrometric analysis
10/12/1999	US5965362 Comparative genomic hybridization (CGH)
10/12/1999	US5965361 In-situ hybridization method using RecA protein and RecA protein having marker or ligand for use in said method
10/12/1999	US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/12/1999	US5965358 Providing an aliquot, producing charged fragments from the aliquot, detecting fragments by a detector which produces a signal corresponding to the mass-to-charge ratio of the detected fragments, evaluating purity using a standard signal
10/12/1999	US5965354 Obtaining biological sample with suspected antibody, reacting sample with type-specific antigens bound to solid support, allowing binding of antibodies to antigen, detecting with labeled immunoglobulin
10/12/1999	US5965353 An epitope; for a diagnostic kit
10/12/1999	US5965352 Methods for identifying pathways of drug action
10/12/1999	US5965141 Epitopic regions of pneumococcal surface protein a
10/12/1999	US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999	US5965128 Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
10/12/1999	US5964993 Glucose sensor
10/12/1999	CA2155028C Non-radioactive method for detecting a labelled segment and a solution or composition therefor
10/12/1999	CA1340787C Cdnas coding for members of the carcinoembryonic antigen family
10/08/1999	CA2234349A1 Method of reducing boar taint
10/07/1999	WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999	WO1999050662A2 Method of measuring bone resorption rate
10/07/1999	WO1999050659A2 Rapid method for detecting micro-organisms and evaluating antimicrobial activity
10/07/1999	WO1999050642A1 Apparatus and method for infectious disease detection
10/07/1999	WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999	WO1999050460A1 HIGH THROUGHPUT ASSAY FOR DETECTION OF mRNA IN CELLS
10/07/1999	WO1999050459A2 High throughput in vitro screening assays for transcription modulators
10/07/1999	WO1999050458A2 OLIGONUCLEOTIDE PROBES FOR DETECTING ENTEROBACTERIACEAE AND QUINOLONE-RESISTANT $i(ENTEROBACTERIACEAE)
10/07/1999	WO1999050457A1 Directed antisense libraries
10/07/1999	WO1999050456A1 P53-regulated genes
10/07/1999	WO1999050454A2 Coding sequence polymorphisms in vascular pathology genes
10/07/1999	WO1999050453A1 Method for searching steroid sulfatase inhibitors
10/07/1999	WO1999050452A1 Catalytic nucleic acid-based diagnostic methods
10/07/1999	WO1999050451A1 Polymorphism i: linkage of asthma to a locus on chromosome 2
10/07/1999	WO1999050450A1 Polymorphism iii: linkage of atopy to a locus on chromosome 13
10/07/1999	WO1999050449A1 Polymorphism ii: linkage of asthma to a locus on chromosome 4
10/07/1999	WO1999050448A2 Nucleic acid detection method
10/07/1999	WO1999050447A1 METHOD AND NUCLEIC ACID COMPOUND FOR BREAKING DOWN NUCLEIC ACID MOLECULES SYNTHESIZED $i(IN VITRO)
10/07/1999	WO1999050446A1 Method and device for quantifying dna and rna
10/07/1999	WO1999050445A2 Detection method for tumor cells
10/07/1999	WO1999050444A1 Reagent compositions for assaying electrolytes
10/07/1999	WO1999050443A1 A method for isolating inhibitors of protease activity
10/07/1999	WO1999050441A1 A selective assay for determining the identity of live microorganisms in a mixed culture
10/07/1999	WO1999050439A2 Anthrax lethal factor is a mapk kinase protease
10/07/1999	WO1999050437A1 Methodology for predicting and/or diagnosing disease
10/07/1999	WO1999050436A1 Method of preparing polypeptides in cell-free system and device for its realization
10/07/1999	WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	WO1999050416A1 Tnf-related death ligand
10/07/1999	WO1999050402A1 Systematic identification of essential genes by in vitro transposon mutagenesis
10/07/1999	WO1999050401A1 Method for detecting change in gene expression by treating with test compound
10/07/1999	WO1999050396A1 Nek1-related protein kinase
10/07/1999	WO1999050385A2 Regulation of glycosaminoglycan synthesis, methods and reagents related thereto
10/07/1999	WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999	WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999	WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999	WO1999049888A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999	WO1999049876A2 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
10/07/1999	WO1999049803A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
10/07/1999	WO1999049774A2 Methods for the diagnosis and treatment of lung cancer
10/07/1999	WO1999045152A8 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
10/07/1999	WO1999041614A3 Method for detecting intimin producing microorganisms
10/07/1999	WO1999040220A3 Method of screening therapeutic agents
10/07/1999	WO1999039174A3 An automatic method of classifying molecules
10/07/1999	WO1999039001A3 Nucleic acid analysis method
10/07/1999	WO1999038962A3 Compositions and methods for using a lysing matrix for isolating dna
10/07/1999	WO1999038888A3 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
10/07/1999	WO1999036102A9 GENETIC MANIPULATION BY 3' UNTRANSLATED SEQUENCES OF mRNA

1 ... 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 ... 3003